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Abstract
The poisonous bite by Hippasa partita, a funnel web spider from the Indian subcontinent has been demonstrated to give rise to severe dermo-
and myonecrosis. In this work a hemorrhagic metalloprotease, Partitagin was purified from H. partita venom by successive chromatography on
Sephadex G-100, DEAE Sephadex A-50 and Biosep DEAE columns. SDS-PAGE, reversed phase HPLC on a C4 column, N-terminal amino acid
sequencing and MALDI-TOF mass spectrometry confirmed the homogeneity. Partitagin was assayed using fat free casein as substrate. EDTA,
1,10-phenanthroline and cyanide, inactivated it irreversibly while, EGTA, PMSF, leupeptin, pepstatin and aprotinin did not inhibit. The presence
of Znþ2 was confirmed by atomic absorption spectrometry. Partitagin caused hemorrhage when tested in a mouse model. Light microscopy of
skin tissue sections at the site of injection revealed extensive damage of extracellular matrix (ECM) in which the basement membrane surround-
ing blood vessels and capillaries showing signs of extensive destruction and also loss of vessel wall integrity. Similar intense damage was also
noticed in the ECM of muscle tissue sections but with no damage caused to myocytes. Partitagin showed specificity of action on the components
of ECM and degraded collagen type-IV and fibronectin but not collagen type-I. Partitagin was devoid of edema, myotoxicity and lethality. This is
the first report on the isolation and characterization of a toxin from spider venom in the Indian subcontinent.
 2007 Elsevier Masson SAS. All rights reserved.
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Hemorrhage and an eventual necrosis of the tissue at the enve-
nomed region are reported in several spider bites [1e5]. Predom-
inantly, zinc dependent metalloproteases of the ‘metzincin’
family enzymes of the venom are found responsible for this toxic
property [6e8]. Hemorrhage is caused due to the destruction of
structural components of basement membrane surrounding blood
vessels and capillaries. Basement membrane is a highly special-
ized type of extracellular matrix and plays a key scaffolding role
in endothelium and other cell types. It holds several structural
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doi:10.1016/j.biochi.2007.04.005components of the extracellular matrix such as collagen type-
IV, fibronectin, laminin, entactin and some glycosaminoglycans.
However, the molecular composition of the basement membrane
tends to vary among different tissues and cell types [9,10]. Fibro-
nectin molecule present in the basement membrane bridges the
cells and the extracellularmatrixand alsoadjacent cells ina tissue.
The binding specificity is achieved by the RGD sequence at the
interaction sites [11]. Degradation of basement membrane com-
ponents predominantly by matrix degrading metalloproteases is
found responsible for the venom induced hemorrhage and tissue
necrosis at the bitten region. Several such proteases have been iso-
lated and studied extensively from spider venoms [12e16] and as
well as from snake venoms [17,8].
In our earlier study on the comparative examination,
Hippasa partita venom induced hemorrhage in mice, while
the other two, Hippasa agelenoides and Hippasa lycosinad.
1323S. Nagaraju et al. / Biochimie 89 (2007) 1322e1331venoms did not [18]. Therefore, H. partita venom was inves-
tigated further for the hemorrhagic activity, and isolated
a 29.129 kDa Znþ2 dependent metalloprotease. The protease
was found to cause hemorrhage in mice and showed in vitro
degradation of several structural proteins of the extracellular
matrix and the results of which are presented in this
manuscript.
2. Materials and methods
H. partita female spiders were collected from Irpu falls re-
gion, Madikeri district (Western Ghats in Karnataka) during
February to April. The spiders were identified based on Tikader
and Malhotra [19] and confirmed by Dr. Manju Siliwal, Wild-
life Information and Liaison Development Society, Zoo Out-
reach Organization, Coimbatore, Tamilnadu. Sephadex
G-100, DEAE Sephadex A-50, fat free casein, gelatin, collagen
type-IV (from EngelbretheHolmeSwarm murine sarcoma
basement membrane), fibronectin (from human plasma), colla-
gen type-I (from rat tail tendon), ethylene diamine tetraacetic
acid (EDTA), potassium cyanide (KCN), phenyl methyl sulfo-
nyl fluoride (PMSF), aprotinin, ethylene glycol-N,N,N0,N0-
tetracetic acid (EGTA), 1,10-phenanthroline, pepstatin and
leupeptin were purchased from Sigma Chemicals Co. St Louis,
USA. Molecular weight markers were from Biorad Company,
USA. LDH and CK diagnostic kits were from AGAPEE
(India). Daboia russelii venom was purchased from Hindustan
Park, Kolkata, India. All other chemicals used were of analyt-
ical grade. Swiss Wister albino mice weighing 20e25 g (from
the central animal house facility, Department of Zoology, Uni-
versity of Mysore, Mysore, India) were used for pharmacolog-
ical studies. Animal care and handling complied with the
National Regulation for Animal Research.
2.1. Preparation of venom gland extract
Venom was extracted from wild caught spiders (around 200
in number) that were kept for five days without food but with
water. The venom gland extract was prepared as previously de-
scribed [15]. Briefly, adult female spiders were anaesthetized
using chloroform inhalation, dissected and a pair of glands
was collected into ice cold phosphate buffered saline (PBS).
The glands were washed in PBS in order to remove possible
contaminants and venoms were harvested in PBS by gentle
compressing of the glands. The suspension was clarified by
centrifugation at 8000 g and the venom gland extract was
stored at 20 C until use.
2.2. Sephadex G-100 column chromatography
The lyophilized H. partita venom gland extract sample:
100 mg in 1.0 ml of 0.1 M NaCl was applied on to a Sephadex
G-100 column (1.5 75 cm) that was equilibrated with 0.1 M
NaCl. The column was eluted using 0.1 M NaCl with a flow
rate of 22 ml/h and 2.2 ml fractions were collected. Protein
elution was monitored at 280 nm using Shimadzu spectropho-
tometer (1601 A˚). Alternative tubes were assayed forproteolytic activity using fat free casein as substrate. Fractions
having enzyme activity were pooled and concentrated.
2.3. DEAE Sephadex A-50 column chromatography
The proteolytic fraction recovered from the previous step:
8 mg in 2 ml of the equilibrating buffer was loaded onto the
DEAE-Sephadex A-50 column (1.6 25 cm) that was equili-
brated with 10 mM TriseHCl buffer pH 7.4. Subfractions
were then eluted stepwise using 10 mM TriseHCl buffer pH
7.4 containing different molarities of NaCl (0.02e0.4 M).
Fractionation was carried out at a flow rate of 20 ml/h and
2 ml fractions were collected. Finally fractions showing pro-
teolytic activity were pooled and concentrated.
2.4. High-pressure liquid chromatography
The proteolytic fraction recovered from the previous step:
0.65 mg in 0.3 ml equilibrating buffer was loaded on to the
Vydac Biosep DEAE-P column (7.55 75 mm) that was
equilibrated with 10 mM TriseHCl buffer pH 7.4 containing
30 mM NaCl. Subfractions were eluted using linear gradient
of 10 mM TriseHCl buffer pH 7.4 containing 30e120 mM
NaCl. Flow rate was 0.5 ml/min and 1 ml fractions were col-
lected. Proteolytic fractions were pooled and concentrated to
obtain Partitagin.
2.5. Proteolytic activity
Proteolytic activity was assayed according to the method of
Satake et al. [20]. Fat free casein (0.4 ml, 2% in 0.2 M Trise
HCl buffer pH 7.6) was incubated with 50 mg of Partitagin in
1 ml of the total volume at 37 C for 2 h 30 min. Adding 1 ml
of 0.44 M trichloroacetic acid and left to stand for 30 min
stopped the reaction. The mixture was then centrifuged at
2000 g for 10 min. Sodium carbonate (2.5 ml, 0.4 M) and Folin
ciocalteus reagent (diluted to 1/3 of the original strength) were
added to 1 ml of the supernatant and the color developed was
read at 660 nm. One unit of enzyme activity was defined as the
amount of the enzyme required to cause an increase in OD of
0.01 at 660 nm/min at 37 C. The specific activity was expressed
as the units/min/mg of protein. For inhibition studies, similar
reaction was performed independently after pre-incubation of
Partitagin for 30 min with 5 mM each of EDTA, 1,10-phenan-
throline, EGTA, PMSF, aprotinin, and 2.5 mM of pepstatin and
leupeptin. In all the cases appropriate controls were kept.
2.6. SDS-polyacrylamide gel electrophoresis
SDS-PAGE was carried out according to the method of
Laemmli [21]. Molecular weight standards from 14.3 to
200 kDa were used. Electrophoresis was carried out using
Tris (25 mM), glycine (192 mM) and SDS (0.1%) for 3 h at
90 V at room temperature. After electrophoresis, gels were
stained with 0.1% Coomassie brilliant blue R-250 for detec-
tion of the protein bands and destained with 25% ethanol
and 8% acetic acid.
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SDS-PAGE was carried out as mentioned above. PAS stain-
ing was done according to the method of Leach et al. [22].
2.8. Zymogram experiments
SDS-PAGE (10%) was carried out according to the method
of Laemmli [21] and polymerized at a final concentration of
0.2% with gelatin/casein. Partitagin (10 mg protein) was pre-
pared under non-reduced condition. Electrophoresis was car-
ried out using Tris (25 mM), glycine (192 mM) and SDS
(0.1%) for 3 h at 90 Vat room temperature. After electrophore-
sis, gels were washed with 10 mM sodium phosphate buffer pH
7.6 containing 2.5% of Triton X-100 with shaking for 1 h to re-
move SDS and incubated overnight at 37 C in TriseHCl buffer
(50 mM) pH 7.6 containing 10 mM CaCl2 and 150 mM NaCl.
Gels were then stained with Coomassie brilliant blue R-250.
2.9. Reversed phase-HPLC (RP-HPLC)
Partitagin was subjected to RP-HPLC using Vydac-C4 col-
umn (5 mm, 0.21 25 cm) column, which had been pre-
equilibrated with 0.1% TFA in water. The column was eluted
using linear gradient from solution A (0.1% TFA in water) to
100% solution B (0.1% TFA in acetonitrile) for 40 min. the
protein was eluted at a flow rate of 1 ml/min and monitored
at 280 nm.
2.10. Mass spectrometry
The molecular mass of Partitagin was determined by mass
spectrometry using Bruker Daltonics Matrix-Assisted Laser
Desorption Ionization Time Of Flight (MALDI-TOF) machine
in positive ionization mode. a-Cyano-4-hydroxycinnamic acid
was used as MALDI matrix.
2.11. Metal analysis
Metal content in Partitagin was determined by atomic
absorption spectrophotometry on an AA-670, Shimadzu spec-
trophotometer. Sample was dissolved in deionized water and
parallel water control was also analyzed for metal content.
2.12. N-terminal sequencing
N-terminal sequence of Partitagin was analyzed by auto-
mated Edmann degradation method on Applied Biosystems
Procise 494 protein sequencer connected to HPLC.
2.13. Hemorrhagic activity
Hemorrhagic activity was assayed as described by Kondo
et al. [23]. Partitagin was injected (intradermally) in different
concentration (5, 10, 15 and 20 mg) in to groups of six mice
each in 50 ml saline. Group receiving saline alone served as
negative control. After 3 h mice were anaesthetized usingdiethyl ether and sacrificed. Dorsal patch of skin surface was
carefully removed, without stretching, and the diameter of
the hemorrhagic spot on the inner surface of the skin was mea-
sured. The minimum hemorrhagic dose (MHD) was defined as
the amount of the hemorrhagin capable of producing 10 mm of
hemorrhage in diameter.
2.14. Myotoxicity
Myotoxicity was determined according to the method of
Gutierrez et al. [24]. Cytoplasmic marker enzymes, lactate
dehydrogenase (LDH, EC no: 1.1.1.28) and creatine phospho-
kinase (CK, EC no: 2.7.3.2) levels were determined in the se-
rum. Partitagin (2.5 mg/kg body weight) and D. russelii venom
(1.25 mg/kg body weight, i.e., 1/2 LD50) in 50 ml saline were
injected intramuscularly into the right thigh of a separate
group of mice (n¼ 6) and served as positive control. The
group receiving 50 ml saline alone served as negative control.
Mice were anaesthetized after 3 h by diethyl ether inhalation.
Abdominal cavities were opened and blood was drawn from
the abdominal vena cava. The 1:25 diluted serum was assayed
for LDH and CK activities using AGAPEE diagnostic kits.
LDH and CK activities were expressed as units/l.
2.15. Histopathology studies
Partitagin was injected intradermally at the dose of 20 mg
(2 MHD), and intramuscularly at a concentration of 2.5 mg/kg
body weight into different group of six mice each, in a total
volume of 50 ml of saline. Control mice received saline alone.
After a period of 2, 4, 6, 8 and 10 h the animals were sacri-
ficed. Skin and muscle tissues dissected out from site of toxin
injection were fixed in Bouin’s solution, and subjected to de-
hydration by processing the tissues through different grades
of alcohol and chloroform: alcohol mixture. The processed tis-
sue was embedded in paraffin and cut into 4-mm thick sections.
The sections were stained with hematoxylineeosin staining
for microscopic observations. The sections were observed
under Leitz wetzlar Germany type-307-148.002 microscope
and photographs were taken using Photometrics colorsnap
CF camera (made Roper Scientific Photometrics) attached to
the microscope.
2.16. Degradation of extracellular matrix molecules
Collagen type-I and type-IV and fibronectin were incubated
with Partitagin in the ratio of substrate:enzyme (6:1, w/w) in
a total volume of 40 ml of TriseHCl buffer (10 mM) pH 7.4
containing 10 mM NaCl at 37 C. Aliquots of the reaction
mixtures were taken out at different time intervals of 2, 4, 6,
8 and 10 h and the Partitagin was inactivated by the addition
of 20 ml denaturing buffer containing 1 M urea, 4% SDS and
4% b-mercaptoethanol. It was then analyzed on 7.5% SDS-
PAGE. The gels were then quantified using densitometry as
a function of time.
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Protein concentration was determined according to the
method of Lowry et al. [25] using bovine serum albumin
(BSA) as standard.
2.18. Statistical analysis
All the data were presented as mean SD.
3. Results
3.1. Purification and properties of Partitagin
Partitagin, a hemorrhagic metalloprotease has been purified
to the extent of 26-folds from H. partita venom based on mo-
lecular sieving and ion exchange properties. The venom when
fractionated on a Sephadex G-100 column, four peaks were re-
solved. The proteolytic activity was concentrated in the
II-peak (Fig. 1A). Further fractionation of the protease fraction
on a DEAE Sephadex A-50 column indicated the recovery of
proteolytic activity in the III-peak (Fig. 1B). This peak upon
HPLC on a Biosep DEAE-P column, Partitagin showing the
proteolytic activity is eluted as a major peak (Fig. 1C). The to-
tal protein and proteolytic activities loaded and recovered in
each step are summarized in Table 1. Throughout the purifica-
tion, alternative tubes were assayed for proteolytic activity and
the pooled fractions were tested for hemorrhagic activity. In all
the cases, there observed overlapping of proteolytic and hem-
orrhagic activities. Partitagin moved as a sharp band to the
same extent in SDS-PAGE under both non-reduced and re-
duced conditions (Fig. 2A). Similar purity was also suggested
by activity staining when a single transluscent activity band was
seen both in casein and gelatin zymograms (Fig. 2B and C).
Partitagin eluted as a sharp peak with the retention time of
23.6 min in reversed phase HPLC on a C4 column (Fig. 1D).
It revealed a single symmetrical sharp peak at m/e of 29.129
in MALDI-TOF mass spectrometry. It did not reveal any
pink color band when subjected for periodic acid Schiff’s
base staining. The N-terminal sequence analysis of the enzyme
gave the sequence of AYDPDPYKRYSAEHTFFLL. It was op-
timally active at pH 7.6 and at 37 C when assayed in the
range between pH 4e9 and 4e60 C, respectively. Aprotinin,
leupeptin, pepstatin, PMSF and EGTA, each at 5 mM concen-
tration did not inhibit the caseinolytic activity of Partitagin. In
contrast, 1,10-phenanthroline, EDTA and cyanide abolished
the activity of Partitagin. Further, neither extensive dialysis
nor addition of 15 mM ZnCl2 restore the activity. The presence
of Znþ2 in Partitagin was confirmed by atomic absorption
spectroscopy. The molar ratio for protein to Znþ2 calculated
was found to be 1:3. Partitagin induced hemorrhage in mice
and the effect was found to be dose dependent (Fig. 3). The
minimum hemorrhagic dose determined was 10 1 mg. Parti-
tagin was found to be non-lethal to mice up-to the tested dose
(ip) of 10 mg/kg body weight.3.2. Histopathological study
Dermonecrotic effect of Partitagin was evaluated by inject-
ing 2 MHD (20 mg) intradermally to groups of mice (n¼ 6).
Mice were anaesthetized and sacrificed after 2, 6 and 10 h of
injection to remove the skin tissue sample for histological
studies. The tissues were independently processed and 4-mm
thick sections were made for observation under light micro-
scope. Time dependent graded degradation of skin tissue is
shown in Fig. 4. At 2 h of Partitagin injection, initiation of
damage of ECM (Fig. 4Ab), while at 6 h, extensive damage
of basement membrane surrounding blood vessels resulted in
intense hemorrhage and massive infiltration of inflammatory
leukocytes were observed (Fig. 4Ac). However, at 10 h, the
integrity of ECM of dermis and the blood vessels were lost
(Fig. 4Ad). In contrast, intact ECM and the basement mem-
brane surrounding the blood vessels and also no infiltration
of inflammatory leukocytes (Fig. 4Aa) were observed in saline
injected tissue sections. Light microscopic observation of
longitudinal section of muscle tissue treated with Partitagin
is shown in Fig. 5. Intramuscular injection of Partitagin
(2.5 mg/kg body weight) caused disorganization of myofibrils
in which the myocytes were spaced apart and the distance
between myocytes progressively increased with the time of
treatment (Fig. 5bee). However, throughout the study the my-
ocytes were found intact and not damaged and, further, no in-
filtration of inflammatory leukocytes was found. Partitagin
treated muscle sections lost the striated appearance, this is in
contrast to the saline injected tissue section in which the tissue
displayed the normal striated appearance of myocytes
(Fig. 5a). Further, the creatine kinase (CK) and lactate dehy-
drogenase (LDH) levels in the serum of mice injected with
Partitagin did not increase and were in good agreement with
the saline injected mice. While injection of ½ LD50
(1.25 mg/kg body weight) of D. russelii whole venom showed
destruction of the muscle tissue in which extensive damage of
ECM and the myocytes (Fig. 5f) was observed and, in addi-
tion, the serum of mice recorded increased levels of CK and
LDH activities (data not shown).
3.3. Degradation of components of extracellular matrix
The ability of Partitagin to degrade the cementing materials
of extracellular matrix was examined. Partitagin degraded col-
lagen type-IV, the control intact collagen type-IV revealed
three bands corresponding to two a1(IV) (220 kDa and
180 kDa) and one a2(IV) (120 kDa) bands (Fig. 6A). Follow-
ing incubation with Partitagin there observed reduction in the
intensity of both the a1(IV) (220 kDa and 180 kDa) bands and
as well as a2(IV) (120 kDa) band with the subsequent gener-
ation of additional new low molecular weight (about 60 kDa)
band in SDS-PAGE under reduced condition. There observed
initial preferential degradation of a1(IV) (220 kDa band) over
a1(IV) (180 kDa) band while, a2(IV) band was the least pre-
ferred band. At 6 h of incubation, a1(IV) (220 kDa), a1(IV)
(180 kDa) and a2(IV) (120 kDa) bands were degraded to the
extent of about 40%, 30% and 10%, respectively. At 10 h of
1326 S. Nagaraju et al. / Biochimie 89 (2007) 1322e1331Fig. 1. Purification of Partitagin. (A) Sephadex G-100 column chromatography; Hippasa partita venom gland extract sample (100 mg in 1 ml of 0.1 M NaCl) was
loaded on to the column (1.5 75 cm). It was eluted with 0.1 M NaCl at a flow rate of 22 ml/h and 2.2 ml fractions were collected. Protein elution was monitored
at 280 nm (d). Proteolytic activity was determined using casein in alternate fractions at 660 nm (- - - - -). Proteolytic activity was concentrated in peak II.
(B) DEAE Sephadex A-50 column chromatography; peak II obtained from the previous step (8 mg in 1 ml of equilibrating buffer) was loaded on to the column
(1.6 25 cm) that was equilibrated with 10 mM TriseHCl buffer pH 7.4. The column was eluted stepwise using 10 mM TriseHCl pH 7.4 buffer containing
different molarities of NaCl (0.02e0.4 M). Flow rate was adjusted to 20 ml/h and 2 ml fractions were collected. Protein elution was monitored at 280 nm
(d). Alternate tubes were assayed for proteolytic activity on casein at 660 nm (- - - - -). Peak III showed proteolytic activity. (C) Biosep DEAE-P column
chromatography; peak III obtained from the previous step (0.65 mg in 0.3 ml of equilibrating buffer) was loaded on to the column (75 7.55 mm) that was
pre-equilibrated with 10 mM TriseHCl buffer pH 7.4 containing 30 mM of NaCl. The column was eluted stepwise using 10 mM TriseHCl buffer pH 7.4
containing different molarities of NaCl (30e120 mM). Flow rate was adjusted to 0.5 ml/min and 1 ml fractions were collected. Protein elution was monitored
at 280 nm (d). Tubes were assayed for proteolytic activity on casein at 660 nm (- - - - -). (D) RP-HPLC profile on a Vydac-C4 column (5 mm, 0.21 25 cm)
that had been pre-equilibrated with 0.1% TFA in water. Protein was eluted using a linear gradient from solution A (0.1% TFA in water) to 100% solution B
(0.1% TFA in acetonitrile) over 60 min. Protein was eluted at a flow rate of 1 ml/min and monitored at 280 nm.incubation, a1(IV) (220 kDa), a1(IV) (180 kDa) and a2(IV)
(120 kDa) bands were degraded to the extent of about 100%,
80% and 20%, respectively as revealed by densitometry
(Fig. 6A). Further, progressive increased intensity of addi-
tional low molecular weight band generated also suggests col-
lagen type-IV degradation.
Fibronectin is also susceptible for Partitagin activity; Fig. 6B
is showing the time dependent degradation of fibronectin in
which both A (270 kDa) and B (250 kDa) bands were degraded.
The intensity of the bands is progressively diminished as a func-
tion of time. However, there observed initial preference for A
band over B band. At 6 h of incubation A band was degraded
to an extent of 80% while, B band was degraded to the extent
of 40%. At 10 h of incubation both the bands were degraded
completely and form a wide range of low molecular weightbands ranging from 97 to 18 kDa. Among these, bands in the
range of 45e18 kDa were found to be prominent. In contrast,
Partitagin did not degrade any of the bands in collagen type-I
(Fig. 6C). Neither change in intensity of existing bands nor ap-
pearance of new bands seen throughout the incubation period.
4. Discussion
This study describes the isolation and characterization of
Partitagin, which is a zinc dependent hemorrhagic metallopro-
tease from H. partita spider venom. Partitagin has been puri-
fied to the extent of 26-folds with the final protein and
caseinolytic activity yield of 0.6% protein and 19.5% casein-
olytic activity (Table 1). Purity has been adjudged by reversed
phase HPLC on a C4 Vydac column, MALDI-TOF mass
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Summary of purification of Partitagin from H. partita venom
Procedure Total protein (mg) Protein recovery (%) Specific activity (units/mg/min) Total activitya Activity yield (%) Fold purity
Sephadex G-100 column
Whole venom gland extract 100 95 0.49 46.55 100 1
Peak-II 9 9 22 19.8 45.53 4.5
DEAE Sephadex A-50 column
Peak-II from G-100 column 8 100 22 17.6 100 1.0
Peak-III 0.72 9 12.74 9.17 52.10 5.79
Biosep DEAE column
Peak III from DEAE
Sephadex A-50 column
0.65 100 12.74 8.28 100 1.0
Partitagin 0.6 92 12.8 7.68 92.75 1.0
Values are average of two independent experiments.
a One unit of activity is defined as the amount of enzyme required to cause the increase in OD of 0.01 at 660 nm/min at 37 C.spectrometry and N-terminal sequence analysis. Partitagin is
a single chain protein as it revealed single band in SDS-
PAGE under both reduced and non-reduced conditions. Parti-
tagin is not a glycoprotein, as it did not answer for periodic
acid staining. The molecular weight was found to be
29.129 kDa in MALDI-TOF mass spectrometry which agrees
well with the metalloprotease of Loxosceles intermedia venom
[26,27]. Partitagin contained Znþ2, which is not easily disso-
ciable by dialysis, suggesting the tight interaction between
the protein and the metal ion. Metal chelating agents such as
EDTA, 1,10-phenanthroline and cyanide independently inacti-
vated the Partitagin irreversibly, as addition of Znþ2 did not re-
store the activity lost. EDTA and cyanide independently found
to form stable complex with the Znþ2, hence inactivation of
Partitagin. Therefore, Znþ2 appears to play a role in function-
ing of Partitagin. However, its role in maintaining the struc-
tural integrity cannot be ignored. The metal content appears
to be bit more than that reported for several SVMPs, however,
agrees well with the metal content of Lachesis muta muta [27],
Agkistrodon acutus [28], Crotalus horridus horridus [29].
Fig. 2. SDS-PAGE and activity staining pattern of Partitagin. (A) Purification
of Partitagin as shown in SDS-PAGE (10%). Samples containing 75 mg of
venom gland extract (1), 50 mg of Peak II of Sephadex G-100 column (2),
15 mg of Partitagin under non-reduced (3) and reduced condition (4). M
represents the molecular weight markers in kDa (from top to bottom:
myosin-H-chain (200), phosphorylase b (97.4), BSA (68), ovalbumin (43),
carbonic anhydrase (29), b-lactalbumin (18.4) and lysozyme (14.3). (B)
Caseinolytic activity of Partitagin (10 mg) resolved by SDS-PAGE (10%)
under non-reduced condition. (C) Gelatinolytic activity of Partitagin (10 mg)
resolved by SDS-PAGE (10%) under non-reduced condition.SVMPs wherein the protein to metal (Znþ2 and or Caþ2 or
both) ratio has been reported to be over 1:3 [30].
Zinc dependent ‘metzincin’ family metalloproteases are
primarily responsible for both local and systemic hemorrhagic
effects of envenomation [31]. Several metalloproteases of
wide molecular weight range from 22 to 100 kDa have been
studied extensively from various venoms [32], albeit only
few such proteases from spider venoms are included in to
the growing list [33]. Transverse section of hemorrhagic area
of mice skin injected with Partitagin showed progressive der-
monecrotic effect with the degradation of basement membrane
surrounding blood vessels. In the initial 2 h of injection, Parti-
tagin damaged the ECM surrounding blood vessels leading to
extravasation in the hypodermis and also caused initiation of
infiltration of inflammatory PMNLs (polymorphonuclear leu-
kocytes) observed. Following 6 and 10 h of injection, massive
degradation of ECM surrounding blood vessels and capillaries
and subsequent damage of vessel walls, irregular and broken
vessel wall morphology were seen compared to intact and
circular vessel wall morphology of control tissue sections
Fig. 3. Dose dependent hemorrhagic activity of Partitagin. Different concentra-
tions of Partitagin was independently injected intradermally in to groups of
mice in a total volume of 50 ml saline. A, B, C, D and E represents the samples
containing saline alone and 5, 10, 15 and 20 mg of Partitagin in saline, respec-
tively. After 3 h, mice were sacrificed, dorsal patch of skin surface was
removed, and diameter of the hemorrhagic spot on the inner surface of the
skin was measured in mm.
1328 S. Nagaraju et al. / Biochimie 89 (2007) 1322e1331Fig. 4. Light micrograph of transverse section of mouse skin. (A) Light micrograph of transverse section of mouse skin taken at various time intervals following
intradermal injection of Partitagin (2 MHD, 20 mg). (a) Control section injected with saline, (b) (c) and (d) are tissue sections taken after 2, 6 and 10 h after
injection of Partitagin, respectively. Indicating intact ECM and blood vessels (a), inflammatory reaction in dermal blood vessel (b), destruction of ECM
(c), and destruction of blood vessels (d). Bar represents 100 mm. (B) A high power view of transverse section taken at 6 h after intradermal injection of Partitagin.
(a) Control section showing the intact blood vessel wall and surrounding tissue, (b) Partitagin treated skin section showing the damaged blood vessel wall and
destruction of surrounding tissue, and (c) section showing the infiltration of polymorphonuclear leukocytes. Bar represents 50 mm.
1329S. Nagaraju et al. / Biochimie 89 (2007) 1322e1331Fig. 5. Light micrograph of longitudinal section of mouse skeletal muscle. (a) Section from control mice injected with saline, note the characteristic striation and
intact myoblasts, sections (b) (c) (d) and (e) are 2, 4, 6 and 8 h after the injection of Partitagin (2.5 mg/kg body weight). There observed the progressive disor-
ganization of myoblasts, but with less infiltration of PMNLs. (f) Section injected with Daboia russelii whole venom (1.25 mg/kg body weight) showing the
destruction of myoblasts with extensive infiltration of PMNLs. Bar represents 100 mm.(see Fig. 4Ba). Selected and/or limited cleavages of key pep-
tide bonds of basement membrane proteins of blood vessel en-
dothelium appear to weaken the capillary wall leading to
extravasation. Similar observations were made with the studies
using L. intermedia venom [13]. Infiltration and confluence of
PMNLs are a natural response for tissue destruction, and this
could be due to the action of Partitagin resulting in generation
of PMNLs recruiting proteolytic peptide fragments either from
collagen type IV or fibronectin or from both.
Partitagin was also evaluated for muscle tissue destruction
property. Longitudinal section of muscle tissue showed no
signs of destruction of myocytes, however, clear and noticeable
progressive disorganization of the striated myofibrils seen with
the increased time of treatment but with no infiltration ofinflammatory PMNLs (Fig. 5bee). While, no increased serum
CK and LDH activities were recorded as the activity of these
enzymes agrees well with the values of saline injected control
mice. Thus, Partitagin is devoid of myotoxicity, while specifi-
cally act on the ECM of tissues. Further, less or no infiltration
of PMNLs possibly suggests little or no generation of PMNLs
recruiting proteolytic peptides, which, otherwise seen abun-
dantly in case of skin tissue sections. This could probably ex-
plain the varied specificity of action of Partitagin in different
tissues or varied relative abundance of different ECM compo-
nents. In contrast, mice injected (im) with the D. russelii whole
venom showed extensive necrosis, disorganized ECM and
damaged myocytes and flocks of PMNLs; also, the serum re-
corded the increased levels of serum CK and LDH enzymes.
1330 S. Nagaraju et al. / Biochimie 89 (2007) 1322e1331BjussuMP-I, a hemorrhagic metalloprotease isolated from
Bothrops jararacussu venom showed hemorrhagic activity
and hydrolysed collagen type IV but devoid of myotoxicity
[34]. The precise mechanism of hemorrhagic function has
not been fully elucidated for metalloproteases, however, it is
widely accepted that proteolytic degradation of basement
membrane components of capillary vessels is a key step [8].
B. jararacussu metalloprotease, BjussuMP-I, has been sug-
gested to degrade basement membrane of capillary vessels,
and hence becoming thinner and eventually developing gaps
Fig. 6. Degradation of extracellular matrix components by Partitagin. (A) Col-
lagen type-IV (B) fibronectin and (C) collagen type-I. Respective ECM compo-
nents were incubated independently with Partitagin in the ratio of 6:1
(substrate:enzyme, w/w) at 37 C for different time intervals and analyzed on
SDS-PAGE (7.5%) under reduced condition. In respective cases; lane 1: Intact
molecule, and lane 2: 2 h, lane 3: 4 h, lane 4: 6 h, lane 5: 8 h and lane 6: 10 h of
Partitagin incubation and lane M represents the standard molecular weight
markers in kDa (from top to bottom) myosin-H-chain (200) phosphorylase
b (97.4), ovalbumin (45.0), carbonic anhydrase (31.0), trypsin inhibitor
(21.5), b-lactalbumin (18.4) and lysozyme (14.4).in their continuity, leading to extravasation [35]. In general,
hemorrhage seems to be the early symptom due to the action
of metzincin family enzymes; continued action of these en-
zymes would result in necrosis of the local tissue. Nevertheless,
local tissue destruction during natural envenomation is due to
cumulative effect of ECM degrading metalloproteases and
hyaluronidases and myonecrotic property of myonecrotic phos-
pholipase A2 enzymes of venom [36,37]. In addition, victim’s
secondary activated extracellular matrix degrading proteases
following envenomation cannot be ignored.
Partitagin selectively degraded collagen type-IV (Fig. 6A)
and fibronectin (Fig. 6B), while it did not degrade collagen
type-I (Fig. 6C). Collagen type-IV is the major component
of basement membrane surrounding blood vessels. It forms
network with laminin via nidogen/entactin of basic basement
membrane scaffold with which other proteins and proteogly-
cans interact to form mature basement membrane. Thus, deg-
radation of collagen type-IV might lead to structural collapse/
impairment in basement membrane integrity [8]. Collagen
type-IV degradation has been associated with the ability to in-
duce hemorrhage in many snake venom metalloproteases [38].
Immunofluorescence staining studies indicated the association
of fibronectin with the subendothelial extracellular matrix.
Degradation of fibronectin will render the structure of the
endothelium more susceptible for damage [12,13,16]. Thus,
degradation of basement membrane collagen type-IV and
fibronectin molecules in the blood vessels appears to be the
key process for the hemorrhage caused by Partitagin and prob-
ably whole venom as well. Fibronectin is implicated in such
physiological functions as tissue repair, blood clotting and
cell migration/adhesion, it serves as adhesion molecule by an-
choring cells to collagen or proteoglycan substrates [39]. The
defective wound healing observed in some cases of L. interme-
dia envenomation was ascribed to the fibronectinolytic activity
of the venom, since fibronectineintegrin interaction is neces-
sary to bridge adjacent cells in a tissue for wound healing
[11]. The fact that limits further discussion is the lack of infor-
mation on structureefunction, and systematic classification of
spider venom metalloproteases. However, the molecular size
of Partitagin agrees well with the molecular size 20e30 kDa
of P-I class of snake venom hemorrhagic metalloproteases [6].
In summary, a 29.129-kDa Znþ2 dependent hemorrhagic
metalloprotease Partitagin has been isolated from H. partita spi-
der venom. Partitagin appears to play role in the venom induced
hemorrhagic activity and efforts have been made to understand
the possible molecular mechanism of its hemorrhagic activity
through in vitro selective degradation of components of the
basement membrane surrounding blood vessels and capillaries.
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